SCHEMBL22236820

SCHEMBL22236820

CCCCCCC1CCC(c2cncc(N3CCN(CC(=O)NC(C)C)CC3)c2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ CYP11B2 P19099 6/20 0.39
▸ UGT8 Q16880 2/20 0.37
▸ TLR9 Q9NR96 1/20 0.36
▸ TLR8 Q9NR97 1/20 0.36
▸ TLR7 Q9NYK1 1/20 0.36
▸ CYP11B1 P15538 1/20 0.35
▸ PTPN11 Q06124 1/20 0.35
▸ S1PR1 P21453 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ MAPT P10636 1/20 0.35
▸ GFER P55789 1/20 0.35
▸ ATM Q13315 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18791007 0.85 ALDH1A1 (0.46) ALDH1A1KDM4ESMN1; SMN2TDP1CYP11B2
SCHEMBL22236774 0.73 ALDH1A1 (0.52) ALDH1A1KDM4ESMN1; SMN2TDP1CYP11B2
SCHEMBL18791083 0.73 ALDH1A1 (0.52) ALDH1A1KDM4ESMN1; SMN2TDP1CYP11B2
SCHEMBL22236812 0.69 CYP11B2 (0.51) ALDH1A1KDM4ESMN1; SMN2TDP1CYP11B2
SCHEMBL23679948 0.68 CYP11B2 (0.53) ALDH1A1KDM4ESMN1; SMN2TDP1CYP11B2
SCHEMBL18791006 0.68 CYP11B2 (0.42) ALDH1A1KDM4ESMN1; SMN2TDP1CYP11B2
SCHEMBL29342911 0.66 CHRM5 (0.55) ALDH1A1KDM4ESMN1; SMN2TDP1TP53
SCHEMBL26744518 0.65 CHRM5 (0.50) ALDH1A1KDM4ESMN1; SMN2TDP1MEN1
SCHEMBL29322471 0.63 CHRM5 (0.48) ALDH1A1KDM4ESMN1; SMN2TDP1HTT
SCHEMBL29324226 0.63 CHRM5 (0.48) ALDH1A1KDM4ESMN1; SMN2TDP1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10717731-B2 Nitrogen-containing aromatic heterocyclic compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2020-07-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10717731-B2 Nitrogen-containing aromatic heterocyclic compound REN, NR3C2, NR5A1 ALDH1A1 1495/4885KDM4E 2819/4885SMN1; SMN2 4151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback